In a pharmaceutical laboratory
Media playback is unsupported on your device

Russia's health sector seeks new money

Pharmsynthez is the latest Russian pharmaceutical company making its stock market debut, with its listing in Moscow planned for 24 November.

It has been a choppy ride for Russian IPOs so far this year due to the volatility in global markets and concerns about valuations and the business climate for foreign investors.

However, the health sector is seen as one of the biggest future growth markets in Russia.

So what are the prospects for the pharmaceutical industry? Emma Simpson went to find out.

For more on the programme visit Russia Business Report.

  • 30 Oct 2010